|
CHRNA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0028999999977E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.795120E-03 |
| Normal-vs-Stage2 |
2.603000E-03 |
| Normal-vs-Stage3 |
1.020270E-03 |
| Normal-vs-Stage4 |
3.197000E-03 |
| Stage1-vs-Stage2 |
3.004000E-01 |
| Stage1-vs-Stage3 |
7.860200E-01 |
| Stage1-vs-Stage4 |
8.680400E-02 |
| Stage2-vs-Stage3 |
3.729000E-01 |
| Stage2-vs-Stage4 |
3.496800E-01 |
| Stage3-vs-Stage4 |
1.102010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31659999999634E-05 |
| Normal-vs-AfricanAmerican |
7.487600E-02 |
| Normal-vs-Asian |
3.829800E-01 |
| Caucasian-vs-AfricanAmerican |
8.185000E-01 |
| Caucasian-vs-Asian |
2.238200E-01 |
| AfricanAmerican-vs-Asian |
3.625000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63784999999139E-05 |
| Normal-vs-Female |
6.422700E-03 |
| Male-vs-Female |
1.916820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.238340E-02 |
| Normal-vs-Age(41-60Yrs) |
1.821920E-03 |
| Normal-vs-Age(61-80Yrs) |
5.54939999999338E-05 |
| Normal-vs-Age(81-100Yrs) |
2.904200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.378400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.774800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.471400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.739800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.188800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.973200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.486400E-01 |
| Normal-vs-Grade 2 |
9.803600E-03 |
| Normal-vs-Grade 3 |
2.248700E-04 |
| Normal-vs-Grade 4 |
1.242680E-03 |
| Grade 1-vs-Grade 2 |
8.989400E-01 |
| Grade 1-vs-Grade 3 |
5.494000E-01 |
| Grade 1-vs-Grade 4 |
5.079800E-02 |
| Grade 2-vs-Grade 3 |
7.787900E-02 |
| Grade 2-vs-Grade 4 |
1.587930E-02 |
| Grade 3-vs-Grade 4 |
8.413900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.274300E-02 |
| Normal-vs-ccB subtype |
1.65979999999788E-06 |
| ccA subtype-vs-ccB subtype |
5.565000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.632900E-04 |
| Normal-vs-N1 |
1.156280E-02 |
| N0-vs-N1 |
1.152810E-01 |
|
|
